Penumbra Inc
(STU:0P8)
€
242.6
2.7 (1.13%)
Market Cap: 9.57 Bil
Enterprise Value: 9.50 Bil
PE Ratio: 299.78
PB Ratio: 8.96
GF Score: 88/100 Penumbra Inc at RBC Capital Markets Global Healthcare Conference Transcript
May 16, 2023 / 03:30PM GMT
Release Date Price:
€286
(-2.05%)
Shagun Singh Chadha
RBC Capital Markets, Research Division - Research Analyst
RBC's 2023 Global Healthcare Conference. I'm Shagun Singh, Senior Medical Device Analyst here at RBC. And I'm very pleased to have Penumbra presenting here with us for the fireside chat.
Joining us here is Jason Mills, Executive Vice President of Strategy at Penumbra. Jason, thank you so much for being here today. We really appreciate it.
Jason Richard Mills
Penumbra, Inc. - EVP of Strategy
Yes. Shagun, great to be here. Thank you for having us. First time here, so it's fun.
Questions & Answers
Shagun Singh Chadha;Jason Richard
RBC Capital Markets, Research Division - Research Analyst
Great. Thank you. Well, so I thought we'll just kick it off with Q1 '23 results, which you just trapped about 2 weeks ago. Maybe we can start with volumes. You guys delivered a pretty strong Q1 number, 20% sequential increase in sales. What were the key growth drivers? And if you could elaborate, that would be helpful.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot